EPZM
Epizyme, Inc
EPZM
EPZM
Delisted
EPZM was delisted on the 11th of August, 2022.
121 hedge funds and large institutions have $965M invested in Epizyme, Inc in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
121
Holders Change
+16
Holders Change %
+15.24%
% of All Funds
2.62%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
36
Increased
41
Reduced
28
Closed
20
Calls
$266K
Puts
$1.32M
Net Calls
-$1.05M
Net Calls Change
-$1.05M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
$43.1M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$26.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$67.5M |
| 4 |
AG
Artal Group
Luxembourg
|
$21.7M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
$20.3M |
Top Sellers
| 1 |
Jennison Associates
New York
|
$8.8M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
$8.18M |
| 3 |
Marshall Wace
London,
United Kingdom
|
$2.38M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$0 |
| 5 |
BlackRock
New York
|
$60.6M |
